Movement Alert｜WUXI XDC Rises 4.04% at Open, Singapore BCM3 GMP Release and Interim Results Expectation Provide Dual Catalysts

Market Focus

Aug 20

On August 20, WUXI XDC rose 4.04% at open, trading at 70.8 HKD/share, with turnover of HKD 4.779 million.

On the news front, the company recently announced that its Singapore-based BCM3 dual-function production line for antibody intermediates and drug substance has successfully completed GMP release. This milestone marks a new stage in the company's global capacity expansion, with BCM3 set to work in synergy with the Wuxi-based BCM1 and BCM2 lines to achieve a substantial leap in production capacity. The formulation line DP4 is also expected to complete GMP release by end of August.

Additionally, the company's board is scheduled to meet on August 24 to review interim results for the first half of the year. Sister company WuXi AppTec reported H1 revenue growth of 38.93% YoY and net profit growth of 29.43%, while raising full-year guidance across the board, bolstering sector-wide expectations. Institutional activity also remains supportive, with Schroders PLC having raised its long position to 5.01% earlier this month.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1194795230"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194795230\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194795230?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 09:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194795230","market":"us","top_or_hot":-1,"title":"Movement Alert｜WUXI XDC Rises 4.04% at Open, Singapore BCM3 GMP Release and Interim Results Expectation Provide Dual Catalysts","media":"Market Focus","content":"<p><p>On August 20, WUXI XDC rose 4.04% at open, trading at 70.8 HKD/share, with turnover of HKD 4.779 million.</p><p>On the news front, the company recently announced that its Singapore-based BCM3 dual-function production line for antibody intermediates and drug substance has successfully completed GMP release. This milestone marks a new stage in the company's global capacity expansion, with BCM3 set to work in synergy with the Wuxi-based BCM1 and BCM2 lines to achieve a substantial leap in production capacity. The formulation line DP4 is also expected to complete GMP release by end of August.</p><p>Additionally, the company's board is scheduled to meet on August 24 to review interim results for the first half of the year. Sister company WuXi AppTec reported H1 revenue growth of 38.93% YoY and net profit growth of 29.43%, while raising full-year guidance across the board, bolstering sector-wide expectations. Institutional activity also remains supportive, with Schroders PLC having raised its long position to 5.01% earlier this month.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WUXI XDC Rises 4.04% at Open, Singapore BCM3 GMP Release and Interim Results Expectation Provide Dual Catalysts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WUXI XDC Rises 4.04% at Open, Singapore BCM3 GMP Release and Interim Results Expectation Provide Dual Catalysts\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-20 09:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 20, WUXI XDC rose 4.04% at open, trading at 70.8 HKD/share, with turnover of HKD 4.779 million.</p><p>On the news front, the company recently announced that its Singapore-based BCM3 dual-function production line for antibody intermediates and drug substance has successfully completed GMP release. This milestone marks a new stage in the company's global capacity expansion, with BCM3 set to work in synergy with the Wuxi-based BCM1 and BCM2 lines to achieve a substantial leap in production capacity. The formulation line DP4 is also expected to complete GMP release by end of August.</p><p>Additionally, the company's board is scheduled to meet on August 24 to review interim results for the first half of the year. Sister company WuXi AppTec reported H1 revenue growth of 38.93% YoY and net profit growth of 29.43%, while raising full-year guidance across the board, bolstering sector-wide expectations. Institutional activity also remains supportive, with Schroders PLC having raised its long position to 5.01% earlier this month.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1194795230","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194795230","pubTimestamp":1787188961,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 20, WUXI XDC rose 4.04% at open, trading at 70.8 HKD/share, with turnover of HKD 4.779 million.On the news front, the company recently announced that its Singapore-based BCM3 dual-function...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"走势提醒|无锡XDC开盘上涨4.04%，新加坡BCM3 GMP发布和中期业绩预期提供双重催化剂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On August 20, WUXI XDC rose 4.04% at open, trading at 70.8 HKD/share, with turnover of HKD 4.779 million.On the news front, the company recently announced that its Singapore-based BCM3 dual-function production line for antibody intermediates and drug substance has successfully completed GMP release. This milestone marks a new stage in the company's global capacity expansion, with BCM3 set to work in synergy with the Wuxi-based BCM1 and BCM2 lines to achieve a substantial leap in production capacity. The formulation line DP4 is also expected to complete GMP release by end of August.Additionally, the company's board is scheduled to meet on August 24 to review interim results for the first half of the year. Sister company WuXi AppTec reported H1 revenue growth of 38.93% YoY and net profit growth of 29.43%, while raising full-year guidance across the board, bolstering sector-wide expectations. Institutional activity also remains supportive, with Schroders PLC having raised its long position to 5.01% earlier this month.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}